Industrial Sector Surges as Market Rotation Accelerates Ahead of Key Data
Markets Daniel Marsh

Industrial Sector Surges as Market Rotation Accelerates Ahead of Key Data

Industrial stocks led a market rebound Friday, with the sector ETF rising 2.8% as investors rotated out of technology. Focus shifts to delayed jobs and inflation reports next week.

XLI CAT DIA
Amazon's Massive AI Capex Plan Sends Shockwaves Through Tech Sector
Technology Sarah Chen

Amazon's Massive AI Capex Plan Sends Shockwaves Through Tech Sector

Amazon's projected $200 billion capital expenditure for 2026, significantly above expectations, triggered a 5.6% stock drop while fueling a chip rally. The tech sector faces rotation pressures with software stocks losing $1 trillion in value since late January.

AMZN NVDA AMD AVGO XLK
Data Center Stocks Surge as AI Infrastructure Demand Fuels Rally
Markets Daniel Marsh

Data Center Stocks Surge as AI Infrastructure Demand Fuels Rally

Data center equities posted sharp gains Friday, led by Vertiv's 10% jump, as investors rotated into AI infrastructure plays ahead of key earnings and economic data.

VRT ANET AMAT XLK
Cloud ETFs Rebound as Tech Recovers, Amazon's AI Spending Weighs
Markets Daniel Marsh

Cloud ETFs Rebound as Tech Recovers, Amazon's AI Spending Weighs

Cloud computing ETFs gained 2-4% Friday amid a tech rebound, while Amazon fell 5.6% on concerns over its $200B AI infrastructure plan. Key economic data this week may shift rate expectations.

AMZN SNOW MSFT DDOG
Hims Halts Compounded GLP-1 Pill as FDA Cracks Down, Molina Plunges on Profit Warning
Regulation James Calloway

Hims Halts Compounded GLP-1 Pill as FDA Cracks Down, Molina Plunges on Profit Warning

Hims & Hers discontinues its $49 compounded semaglutide offering following FDA enforcement signals, sending shares down 16%. Molina Healthcare forecasts 2026 profit far below expectations, triggering a 28% stock drop.

HIMS MOH XLV
Communication Services Sector Lags as AI Spending Concerns Weigh on Big Tech
Markets Daniel Marsh

Communication Services Sector Lags as AI Spending Concerns Weigh on Big Tech

The Communication Services ETF (XLC) fell 0.4% Friday, diverging from a broad market rally, as Alphabet and Meta declined. Investors scrutinized massive AI capital expenditure plans.

XLC GOOGL META DIS NFLX TMUS VZ T AMZN NVDA
Quantum Computing Stocks Surge as Tech Sector Rebounds
Technology Sarah Chen

Quantum Computing Stocks Surge as Tech Sector Rebounds

Shares of quantum computing companies soared Friday, with IonQ, Rigetti, D-Wave, and Quantum Computing Inc gaining 15-21% amid a broad tech rally. Heavy trading volume accompanied the moves.

IONQ QUBT
Ucore Rare Metals Surges 15% as Critical Minerals Policy Fuels Sector Rally
Commodities Rebecca Torres

Ucore Rare Metals Surges 15% as Critical Minerals Policy Fuels Sector Rally

Ucore Rare Metals shares jumped nearly 15% on Friday, leading a broader rally in rare earth stocks amid renewed focus on North American critical minerals policy and supply chain security.

UCU USAR CRML GLD
AI Investment Splits Tech as Dow Tops 50,000
Markets Daniel Marsh

AI Investment Splits Tech as Dow Tops 50,000

The Dow Jones Industrial Average closed above 50,000 for the first time, driven by chipmakers like Nvidia, while Amazon fell sharply on news of a massive $200 billion capital expenditure plan for 2026. Investors are scrutinizing soaring AI infrastructure costs.

NVDA AMZN MSFT META GOOG GOOGL QQQ IWM
EV Stocks Rally on UBS Lucid Bet; Stellantis Takes $26.5B Charge
Markets Daniel Marsh

EV Stocks Rally on UBS Lucid Bet; Stellantis Takes $26.5B Charge

Lucid surged 14% after UBS disclosed a major stake, leading a rebound in EV shares. Stellantis plunged up to 30% in Europe after booking a massive $26.5 billion charge related to its electric vehicle strategy.

LCID RIVN TSLA STLA UBS MCHI FXI
Merck Nears 52-Week Peak Amid Insider Sale, Investors Eye Pipeline Updates
Earnings James Calloway

Merck Nears 52-Week Peak Amid Insider Sale, Investors Eye Pipeline Updates

Merck shares climbed 1.8% to $121.93, extending gains for a seventh session and approaching a 52-week high. An executive sold 37,685 shares as investors await the impact of 2026 guidance and pipeline developments.

MRK PFE LLY JNJ XLV
AstraZeneca Shares Hold Ground Ahead of Key Earnings, TrumpRx Pricing Initiative Looms
Earnings James Calloway

AstraZeneca Shares Hold Ground Ahead of Key Earnings, TrumpRx Pricing Initiative Looms

AstraZeneca shares edged higher ahead of its full-year results, with 2026 guidance and U.S. drug pricing pressures in focus. The stock closed up 0.9% in London and 3.2% in New York.

AZN